Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Ohnishi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Plos One|October 22, 2025
Neural mechanisms underlying reward processing and social cognition: A replication study with a Japanese sampleKenta Ohnishi, Michiyo Sugawara, Yoko Mano, et al.
Optics Letters|April 28, 2006
Development of a quasi-phase-matched, second-harmonic generation periodically poled lithium niobate waveguide with an integrated electro-optical modulatorYuji Oki, Hiromitsu Onda, Takahiro Okaguchi, et al.
Prostate International|May 5, 2022
Prostate diseases and microbiome in the prostate, gut, and urineMakito Miyake, Yoshihiro Tatsumi, Kenta Ohnishi, et al.
The Prostate|May 12, 2024
Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: An observational study using propensity score matchingYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
In Vivo (Athens, Greece)|October 30, 2024
Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER TrialMakito Miyake, Nobumichi Tanaka, Kenta Ohnishi, et al.
Case Reports in Urology|January 24, 2023
Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting AgentMakito Miyake, Nobutaka Nishimura, Tatsuki Miyamoto, et al.
Cancers|May 13, 2023
Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder CancerMakito Miyake, Nobutaka Nishimura, Sayuri Ohnishi, et al.
Japanese Journal of Clinical Oncology|April 11, 2023
Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette-GuerinMakito Miyake, Shunta Hori, Tomomi Fujii, et al.
International Journal of Clinical Oncology|January 4, 2019
Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomyYoshitaka Itami, Makito Miyake, Yoshihiro Tatsumi, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 20, 2025
Serum metabolomic analysis identified serum biomarkers predicting tumour recurrence after Bacillus Calmette-Guérin therapy in patients with non-muscle invasive bladder cancerMakito Miyake, Kota Iida, Nobutaka Nishimura, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Plos One|October 22, 2025
Neural mechanisms underlying reward processing and social cognition: A replication study with a Japanese sampleKenta Ohnishi, Michiyo Sugawara, Yoko Mano, et al.
Optics Letters|April 28, 2006
Development of a quasi-phase-matched, second-harmonic generation periodically poled lithium niobate waveguide with an integrated electro-optical modulatorYuji Oki, Hiromitsu Onda, Takahiro Okaguchi, et al.
Prostate International|May 5, 2022
Prostate diseases and microbiome in the prostate, gut, and urineMakito Miyake, Yoshihiro Tatsumi, Kenta Ohnishi, et al.
The Prostate|May 12, 2024
Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: An observational study using propensity score matchingYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
In Vivo (Athens, Greece)|October 30, 2024
Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER TrialMakito Miyake, Nobumichi Tanaka, Kenta Ohnishi, et al.
Case Reports in Urology|January 24, 2023
Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting AgentMakito Miyake, Nobutaka Nishimura, Tatsuki Miyamoto, et al.
Cancers|May 13, 2023
Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder CancerMakito Miyake, Nobutaka Nishimura, Sayuri Ohnishi, et al.
Japanese Journal of Clinical Oncology|April 11, 2023
Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette-GuerinMakito Miyake, Shunta Hori, Tomomi Fujii, et al.
International Journal of Clinical Oncology|January 4, 2019
Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomyYoshitaka Itami, Makito Miyake, Yoshihiro Tatsumi, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 20, 2025
Serum metabolomic analysis identified serum biomarkers predicting tumour recurrence after Bacillus Calmette-Guérin therapy in patients with non-muscle invasive bladder cancerMakito Miyake, Kota Iida, Nobutaka Nishimura, et al.
Pageof 3